Biomed Industries Unveils novel Quadruple Receptor Agonist for weight loss with Minimal Adverse Effects at the International Obesity conference in Las Vegas Dr. Lloyd L. Tran Biomed Industries, Inc.

Cumulative exposure to IGF-1 excess was associated with a higher cancer risk among patients with acromegaly ... Common cancers included breast cancer among women (11%), prostate cancer among men (5.8% ...

Does that sound like a lot or a little? Well, when you consider that a can of regular Coke has 39 grams of sugar, and even ...

Acelyrin's Lonigutamab offers a competitive edge with subcutaneous administration, higher potency, and lower adverse events.

FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S.Phase 3 study for ...

We circle back to three small biotech stocks that recently were positively highlighted and moved up on good news. Explore ...

Learn more about whether ACADIA Pharmaceuticals Inc or Centessa Pharmaceuticals PLC - ADR is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...

With infrastructure spending on the rise, now could be an opportune time to invest in top infrastructure ETFs like Global X U ...